Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio (IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, ...
For years, chimeric antigen receptor (CAR) T cell therapies have led the way in cell-based immunotherapy, offering hope to many patients with certain blood cancers. But now, researchers believe the ...
Cell-based immunotherapies such as chimeric antigen receptor T cells (CAR-T) have transformed cancer care in recent years, dramatically improving the treatment of blood cancers in particular. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results